Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Nabilone for Non-motor Symptoms in Parkinson's Disease [Phase 2]
Phase 2 trial update on nabilone for non-motor symptoms in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial evaluating the dose of WIN-1001X for efficacy and safety in early Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Dental Appliance for Parkinson's Disease [NA]
Clinical trial assessing a dental appliance for Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects [Phase 2]
Phase 2 trial evaluating efficacy, safety, and pharmacokinetics of XP21279 with Sinemet in Parkinson's disease completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
Clinical trial update reporting outcomes assessment for Parkinson's disease patients treated with XADAGO (safinamide).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease. [Phase 2]
Phase 2 trial results for KDT-3594 in early Parkinson's disease have been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa [Phase 4]
A Phase 4 trial comparing sustained-release versus immediate-release pramipexole for nocturnal symptoms in advanced Parkinson disease patien…
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3 [Phase 2]
Phase 2 clinical trial update studying cholinergic mechanisms of gait dysfunction in Parkinson's disease; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease [Phase 2]
Phase 2 results for prasinezumab (RO7046015/PRX002) in early Parkinson's disease have been posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3]) [Phase 2]
Phase 2 crossover study evaluating cholinergic target engagement for gait dysfunction in Parkinson's disease has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Medication Responsiveness in Parkinson's Disease [Phase 2]
Phase 2 clinical trial completed evaluating medication responsiveness in Parkinson's disease, with focus on medication compliance and tappin…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease [Phase 2]
Phase 2 trial evaluating the symptomatic effects of nocturnal sodium oxybate in Parkinson's disease with sleep-wake disturbances completed.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment [Phase 2]
Phase 2 trial investigating orthostatic dysregulation and related GI dysfunction in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease [NA]
Clinical trial update on asymmetric subthalamic deep brain stimulation for axial motor dysfunction in Parkinson's disease; study completed w…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: The Stanford Parkinson's Disease Plasma Study [Phase 1]
Phase 1 clinical trial update for the Stanford Parkinson's Disease Plasma Study, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease [Phase 2]
Phase 2 clinical trial update on AQW051 assessing safety and efficacy for L-dopa induced dyskinesias in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [Phase 2]
Phase 2 trial evaluating modified release AFQ056 for Parkinson's patients with L-dopa induced dyskinesias has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [Phase 2]
Phase 2 trial evaluating AFQ056 for L-dopa induced dyskinesias in Parkinson's patients completed.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [Phase 2]
Open-label Phase 2 trial assessing AFQ056 for safety, tolerability, and efficacy in Parkinson's patients with L-dopa induced dyskinesias com…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia [Phase 2]
Phase 2 trial update evaluating AFQ056 with higher L-dopa doses in Parkinson's disease patients with moderate-severe L-dopa induced dyskines…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [Phase 2]
Phase 2 long-term safety extension study update for AFQ056 in Parkinson's patients with L-dopa-induced dyskinesias.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Vibration Impact on Parkinson's Tremor [NA]
A completed clinical trial evaluating vibration impact on tremor in Parkinson disease; results posted December 17, 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Cognitive Dysfunction in Parkinson's Disease [NA]
A completed clinical trial investigating cognitive dysfunction in Parkinson's disease; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness [Phase 2]
Phase 2 trial update on THN102 for Parkinson's disease with excessive daytime sleepiness; results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness [Phase 2]
Phase 2 trial of BEN-2001 in Parkinson's disease patients with excessive daytime sleepiness has completed and results have been posted.